Relmada Therapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan '26 Jan 26, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	219	15	113	98	549	426
Market Cap Growth	1784.47%	-86.56%	14.70%	-82.10%	28.99%	-13.82%
Enterprise Value	207	-37	17	-74	472	325
Last Close Price	3.16	0.36	-	-	-	-
PB Ratio	27.16	0.44	1.46	0.75	3.00	4.93
P/TBV Ratio	27.16	0.44	1.46	0.75	3.00	4.93
Quick Ratio	2.68	4.36	7.90	11.94	14.08	9.30
Current Ratio	2.86	4.45	8.00	12.26	14.83	9.37
Return on Equity (ROE)	-196.79%	-132.33%	-87.51%	-90.07%	-80.14%	-53.74%
Return on Assets (ROA)	-102.41%	-73.14%	-51.76%	-53.57%	-46.01%	-31.52%
Return on Capital Employed (ROCE)	-597.10%	-236.10%	-121.50%	-114.80%	-60.40%	-56.20%
Earnings Yield	-21.85%	-509.73%	-79.28%	-149.50%	-20.13%	-11.42%
FCF Yield	-	-329.85%	-41.46%	-98.81%	-14.71%	-5.34%
Buyback Yield / Dilution	-5.32%	-0.21%	-1.59%	-68.80%	-12.56%	-68.97%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.